{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T12:36:07Z","timestamp":1771590967285,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-024-02951-7","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T03:45:58Z","timestamp":1727495158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A multicenter study of clinical outcomes and volumetric trends in suspected microprolactinomas"],"prefix":"10.1007","volume":"47","author":[{"given":"Christopher S.","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremi","family":"Chabros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Kilgallon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakob V.E.","family":"Gerstl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chady","family":"Omara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Drexler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Flitsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz L.","family":"Ricklefs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice S.","family":"Ryba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Mazzatenta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Guaraldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carleton E.","family":"Corrales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,28]]},"reference":[{"issue":"5","key":"2951_CR1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"Gillam MP, Molitch ME, Lombardi G, Colao A (2006) Advances in the treatment of prolactinomas. Endocr Rev 27(5):485\u2013534","journal-title":"Endocr Rev"},{"issue":"1","key":"2951_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000497746","volume":"109","author":"L Vroonen","year":"2019","unstructured":"Vroonen L, Daly AF, Beckers A (2019) Epidemiology and Management challenges in Prolactinomas. Neuroendocrinology 109(1):20\u201327","journal-title":"Neuroendocrinology"},{"key":"2951_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jocn.2021.12.003","volume":"95","author":"MN Pernik","year":"2022","unstructured":"Pernik MN, Montgomery EY, Isa S, Sundarrajan C, Caruso JP, Traylor JI et al (2022) The natural history of non-functioning pituitary adenomas: a meta-analysis of conservatively managed tumors. J Clin Neurosci 95:134\u2013141","journal-title":"J Clin Neurosci"},{"issue":"2","key":"2951_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA et al (2011) Diagnosis and treatment of hyperprolactinemia: an endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(2):273\u2013288","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2951_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1210\/jcem-68-2-412","volume":"68","author":"J Schlechte","year":"1989","unstructured":"Schlechte J, Dolan K, Sherman B, Chapler F, Luciano A (1989) The natural history of untreated hyperprolactinemia: a prospective analysis. J Clin Endocrinol Metab 68(2):412\u2013418","journal-title":"J Clin Endocrinol Metab"},{"key":"2951_CR6","unstructured":"Burke WT, Penn DL, Castlen JP, Donoho DA, Repetti CS, Iuliano S et al (2019) Prolactinomas and nonfunctioning adenomas: preoperative diagnosis of tumor type using serum prolactin and tumor size. J Neurosurg. :1\u20138"},{"key":"2951_CR7","unstructured":"Osorio RC, Pereira MP, Oh T, Joshi RS, Haddad AF, Pereira KM et al (2022) Correlation between tumor volume and serum prolactin and its effect on surgical outcomes in a cohort of 219 prolactinoma patients. J Neurosurg. :1\u201311"},{"issue":"1","key":"2951_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12020-021-02744-8","volume":"74","author":"K Wright","year":"2021","unstructured":"Wright K, Lee M, Escobar N, Pacione D, Young M, Fatterpekar G et al (2021) Tumor volume improves preoperative differentiation of prolactinomas and nonfunctioning pituitary adenomas. Endocrine 74(1):138\u2013145","journal-title":"Endocrine"},{"issue":"12","key":"2951_CR9","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","volume":"19","author":"S Petersenn","year":"2023","unstructured":"Petersenn S, Fleseriu M, Casanueva FF, Giustina A, Biermasz N, Biller BMK et al (2023) Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement. Nat Rev Endocrinol 19(12):722\u2013740","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2951_CR10","first-page":"2010","volume":"15","author":"Y Huang","year":"2018","unstructured":"Huang Y, Ding C, Zhang F, Xiao D, Zhao L, Wang S (2018) Role of prolactin\/adenoma maximum diameter and prolactin\/adenoma volume in the differential diagnosis of prolactinomas and other types of pituitary adenomas. Oncol Lett 15(2):2010\u20132016","journal-title":"Oncol Lett"},{"issue":"4","key":"2951_CR11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1365-2265.2006.02627.x","volume":"65","author":"N Karavitaki","year":"2006","unstructured":"Karavitaki N, Thanabalasingham G, Shore HC, Trifanescu R, Ansorge O, Meston N et al (2006) Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin Endocrinol (Oxf) 65(4):524\u2013529","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2951_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1186\/1756-0500-7-555","volume":"7","author":"T Kawaguchi","year":"2014","unstructured":"Kawaguchi T, Ogawa Y, Tominaga T (2014) Diagnostic pitfalls of hyperprolactinemia: the importance of sequential pituitary imaging. BMC Res Notes 7:555","journal-title":"BMC Res Notes"},{"key":"2951_CR13","doi-asserted-by":"publisher","first-page":"901385","DOI":"10.3389\/fendo.2022.901385","volume":"13","author":"A Cho","year":"2022","unstructured":"Cho A, Vila G, Marik W, Klotz S, Wolfsberger S, Micko A (2022) Diagnostic criteria of small sellar lesions with hyperprolactinemia: Prolactinoma or else. Front Endocrinol (Lausanne) 13:901385","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"2951_CR14","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.eprac.2022.03.013","volume":"28","author":"A Faje","year":"2022","unstructured":"Faje A, Jones P, Swearingen B, Tritos NA (2022) The prolactin per unit tumor volume ratio accurately distinguishes Prolactinomas from secondary hyperprolactinemia due to Stalk Effect. Endocr Pract 28(6):572\u2013577","journal-title":"Endocr Pract"},{"issue":"2","key":"2951_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1023\/B:PITU.0000004798.27230.ed","volume":"6","author":"MD Johnson","year":"2003","unstructured":"Johnson MD, Woodburn CJ, Vance ML (2003) Quality of life in patients with a pituitary adenoma. Pituitary 6(2):81\u201387","journal-title":"Pituitary"},{"issue":"2","key":"2951_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s11102-023-01313-8","volume":"26","author":"MAM Stumpf","year":"2023","unstructured":"Stumpf MAM, Pinheiro FMM, Silva GO, Cescato VAS, Musolino NRC, Cunha-Neto MBC et al (2023) How to manage intolerance to dopamine agonist in patients with prolactinoma. Pituitary 26(2):187\u2013196","journal-title":"Pituitary"},{"issue":"1","key":"2951_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/EJE-18-0682","volume":"180","author":"AG Ioachimescu","year":"2019","unstructured":"Ioachimescu AG, Fleseriu M, Hoffman AR, Vaughan Iii TB, Katznelson L (2019) Psychological effects of dopamine agonist treatment in patients with hyperprolactinemia and prolactin-secreting adenomas. Eur J Endocrinol 180(1):31\u201340","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2951_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/EJE-07-0248","volume":"158","author":"J Kreutzer","year":"2008","unstructured":"Kreutzer J, Buslei R, Wallaschofski H, Hofmann B, Nimsky C, Fahlbusch R et al (2008) Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur J Endocrinol 158(1):11\u201318","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2951_CR19","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1530\/EJE-16-0087","volume":"175","author":"M Tampourlou","year":"2016","unstructured":"Tampourlou M, Trifanescu R, Paluzzi A, Ahmed SK, Karavitaki N (2016) THERAPY OF ENDOCRINE DISEASE: surgery in microprolactinomas: effectiveness and risks based on contemporary literature. Eur J Endocrinol 175(3):R89\u201396","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2951_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1046\/j.1365-2265.1999.00748.x","volume":"51","author":"J Feldkamp","year":"1999","unstructured":"Feldkamp J, Santen R, Harms E, Aulich A, Modder U, Scherbaum WA (1999) Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study. Clin Endocrinol (Oxf) 51(1):109\u2013113","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-02951-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-024-02951-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-024-02951-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T10:32:58Z","timestamp":1741084378000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-024-02951-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,28]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2951"],"URL":"https:\/\/doi.org\/10.1007\/s10143-024-02951-7","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,28]]},"assertion":[{"value":"18 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This was a retrospective study conducted under an IRB-approved protocol (#2015P002352) at Brigham and Women\u2019s Hospital in Boston, MA, USA. Due to the retrospective nature of the study, the requirement for informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"703"}}